pyridoxine has been researched along with Glaucoma in 4 studies
4,5-bis(hydroxymethyl)-2-methylpyridin-3-ol: structure in first source
vitamin B6 : Any member of the group of pyridines that exhibit biological activity against vitamin B6 deficiency. Vitamin B6 deficiency is associated with microcytic anemia, electroencephalographic abnormalities, dermatitis with cheilosis (scaling on the lips and cracks at the corners of the mouth) and glossitis (swollen tongue), depression and confusion, and weakened immune function. Vitamin B6 consists of the vitamers pyridoxine, pyridoxal, and pyridoxamine and their respective 5'-phosphate esters (and includes their corresponding ionized and salt forms).
Glaucoma: An ocular disease, occurring in many forms, having as its primary characteristics an unstable or a sustained increase in the intraocular pressure which the eye cannot withstand without damage to its structure or impairment of its function. The consequences of the increased pressure may be manifested in a variety of symptoms, depending upon type and severity, such as excavation of the optic disk, hardness of the eyeball, corneal anesthesia, reduced visual acuity, seeing of colored halos around lights, disturbed dark adaptation, visual field defects, and headaches. (Dictionary of Visual Science, 4th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "It has been shown that eyes instillation of pyridoxine hydrochloride low doses during 20 days affects the vision and tonographic characteristics of patients with glaucoma and earlier stage of cataract." | 7.68 | [Effect of low doses of emoxipine and pyridoxine hydrochloride on the status of patients with cataract and glaucoma]. ( Burlakova, EB; Ianovskaia, NP; Shtol'ko, VN, 1993) |
| "It has been shown that eyes instillation of pyridoxine hydrochloride low doses during 20 days affects the vision and tonographic characteristics of patients with glaucoma and earlier stage of cataract." | 3.68 | [Effect of low doses of emoxipine and pyridoxine hydrochloride on the status of patients with cataract and glaucoma]. ( Burlakova, EB; Ianovskaia, NP; Shtol'ko, VN, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ianovskaia, NP | 1 |
| Shtol'ko, VN | 1 |
| Burlakova, EB | 1 |
| Verin, P | 1 |
| Sekkat, A | 1 |
| Lagoutte, F | 1 |
| Boudet, C | 1 |
| Philippot, M | 1 |
| Arnaud, B | 1 |
| Bartsocas, CS | 1 |
| Levy, HL | 1 |
| Crawford, JD | 1 |
| Thier, SO | 1 |
1 trial available for pyridoxine and Glaucoma
| Article | Year |
|---|---|
[The clinical applications in opthalmology of an original factor in cellular nutrition (piridoxylate].
Topics: Administration, Oral; Aged; Clinical Trials as Topic; Eye Diseases; Female; Glaucoma; Glyoxylates; H | 1974 |
3 other studies available for pyridoxine and Glaucoma
| Article | Year |
|---|---|
[Effect of low doses of emoxipine and pyridoxine hydrochloride on the status of patients with cataract and glaucoma].
Topics: Cataract; Dose-Response Relationship, Drug; Eye Color; Glaucoma; Humans; Picolines; Pyridoxine; Visi | 1993 |
[Clinical experimentation with pyridoxylate in treatment of various chorioretinal degenerative disorders (50 cases)].
Topics: Adult; Aged; Choroid; Diabetic Retinopathy; Glaucoma; Glyoxylates; Humans; Middle Aged; Pyridoxine; | 1969 |
A defect in intestinal amino acid transport in Lowe's syndrome.
Topics: Adult; Arginine; Biopsy; Carbon Isotopes; Cataract; Child, Preschool; Glaucoma; Glycine; Humans; Int | 1969 |